Renal Response Outcomes of the EuroLupus and NIH Cyclophosphamide Dosing Regimens in Childhood-Onset Proliferative Lupus Nephritis.
Christine S WangRebecca E SadunWenru ZhouKristen R MillerLaura PyleStacey P ArdoinChristine BachaEmily HauseJoyce Hui-YuenNicole LingMaria PereiraMeredith RiebschlegerKelly Rouster-StevensAliese SarkissianJulia ShalenWilliam Daniel SoulsbyMarinka TwiltEveline Y WuLaura B LewandowskiScott E WenderferJennifer C Coopernull nullPublished in: Arthritis & rheumatology (Hoboken, N.J.) (2023)
Our study failed to demonstrate a benefit of the NIH regimen over the EuroLupus CYC regimen in childhood-onset proliferative LN. However, future prospective outcome studies are needed.